These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10217375)

  • 1. Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.
    Gaw A; Docherty G; Brown EA; Ford I
    Atherosclerosis; 1999 Apr; 143(2):445-50. PubMed ID: 10217375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect.
    Gaw A; Brown EA; Ford I
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1870-6. PubMed ID: 9848878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.
    Bowden JF; Pritchard PH; Hill JS; Frohlich JJ
    Arterioscler Thromb; 1994 Oct; 14(10):1561-8. PubMed ID: 7918305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
    Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
    Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
    Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG
    Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of the plasma lipoprotein(a) distribution.
    Craig W; Poulin S; Bostom A; Eaton C; Laurino J; Ledue T; Ritchie R
    J Clin Lab Anal; 1995; 9(6):392-6. PubMed ID: 8587008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
    J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO
    Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study.
    Klausen IC; Sjøl A; Hansen PS; Gerdes LU; Møller L; Lemming L; Schroll M; Faergeman O
    Atherosclerosis; 1997 Jul; 132(1):77-84. PubMed ID: 9247362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients.
    von Eckardstein A; Heinrich J; Funke H; Schulte H; Schönfeld R; Köhler E; Steinmetz A; Assmann G
    Arterioscler Thromb; 1993 Feb; 13(2):240-6. PubMed ID: 8427859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
    J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.